Tessa Therapeutics is based in Singapore, Singapore. It has raised $200M in total funding. Latest round: Series A.
Tessa Therapeutics is based in Singapore, Singapore. Tessa Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for Tessa Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Polaris Partners, Temasek, Brandon Capital Partners, EQT Life Sciences, INKEF Capital, Mission BioCapital and 4 others. 10 distinct backers are named across the disclosed rounds.
We update the Tessa Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Singapore and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026